OTHER ARTICLES NOTED
- NSAIDs, Heart Failure Don't Mix. // Clinician Reviews;Mar2009, Vol. 19 Issue 3, p6
The article discusses a study on the link between the use of nonsteroidal anti-inflammatory drugs (NSAIDs) in chronic heart failure and the increased mortality and cardiovascular morbidity. It references a study by G. H. Gislason, J. N. Rasmussen, S. Z. Abildstrom et al which was published in...
- ABIOMED REPORTS ON EUROPEAN GROWTH STRATEGY. // Worldwide Biotech;Feb2008, Vol. 20 Issue 2, p7
The article details the European growth strategy of Abiomed Inc. The company plans to establish recovery as the goal for patients experiencing acute cardiac events. The company's portfolio of circulatory care products including Impella, iPulseTM and AB5000 are approved in 27 European Union...
- Antithrombotic therapy may prevent sudden coronary death. // Modern Medicine;Jul97, Vol. 65 Issue 7, p51
Presents an abstract of the study `Effect of antithrombotic therapy on risk of sudden coronary death in patients with congestive heart failure,' by D.L. Dries, M.J. Domanski, M.A. Waclawiw et al published in the April 1, 1997 issue of the `American Journal of Cardiology.'
- SURVIVING CARDIAC ARREST. Metcalf, Eric; Harrar, Sari // Prevention;Apr2002, Vol. 54 Issue 4, p172
Discusses the use of selective aortic arch perfusion to help treat patients who have gone into cardiac arrest, and discusses how the use of this treatment by emergency medical technicians could keep patients alive longer.
- Use of vasopressin and corticosteroids improves cardiac arrest survival. // JAAPA: Journal of the American Academy of Physician Assistants (;Sep2009, Vol. 22 Issue 9, p56
The article presents a study to examine the efficacy of vasopressin and corticosteroids to treat cardiac arrest. In this study, patients with postresuscitation shock who received stress doses of a corticosteroid had higher rates of survival to hospital discharge. It found that the use of...
- Medical Management of Advanced Heart Failure. Nohria, Anju; Lewis, Eldrin; Stevenson, Lynne // JAMA: Journal of the American Medical Association;2/6/2002, Vol. 287 Issue 5, p628
Presents a study to review medical therapy for advanced heart failure as of February 6, 2002. Context; Objective; Data sources; Study selection; Data extraction; Data synthesis; Conclusion that management of advanced heart failure is based more on consensus than on randomized trials, and that...
- Heart Pump Approved for Permanent Use. // FDA Consumer;Jan/Feb2003, Vol. 37 Issue 1, p5
The U.S. Food and Drug Administration (FDA) has approved a heart assist pump to be implanted permanently in certain terminally ill patients who are not eligible for heart transplant. The device, called HeartMate, is a left ventricular assist device (LVAD) made by Thoratec Corporation of...
- Automatic defibrillator approved for sale without a prescription. Lenzer, Jeanne // BMJ: British Medical Journal (International Edition);9/25/2004, Vol. 329 Issue 7468, p703
Reports that the United States Food & Drug Administration has granted "over the counter" status to Phillips Medical's automatic external defibrillator. Reason for the move which include a finding that 95% of US adult deaths come from sudden cardiac arrest which occur outside a hospital and most...
- Randomised comparison of methyldopa and oxprenolol for treatment of hypertension in pregnancy. Gallery, E.D.M.; Saunders, D.M.; Hunyor, S.N.; Gyory, A.Z. // British Medical Journal;6/16/1979, Vol. 1 Issue 6178, p1591
Reports the comparison of methyldopa and oxprenolol drugs for treatment of hypertension in pregnancy. Differences in the outcome of the treatment between the two drugs; Effectiveness of oxprenolol in controlling hypertension during pregnancy; Advantages of oxprenolol over methyldopa.